FIGURE 7.

An external file that holds a picture, illustration, etc.
Object name is zbc0350846260007.jpg

Roles of ubiquitination in the life cycle of agonist-stimulated β2AR. Step 1, within seconds of agonist exposure, β2ARs stimulate Gs and adenylyl cyclase, increasing cellular cAMP. Step 2, agonist-occupied receptors are also phosphorylated by GRKs on cytoplasmic domain seryl and/or threonyl residues, within seconds to minutes of agonist exposure. Step 3, cytosolic β-arrestin2 (βarr2) translocates to phosphorylated receptors within 1–5 min after agonist treatment. Agonist-dependent β-arrestin ubiquitination (U) occurs immediately upon β-arrestin recruitment and is mediated by Mdm2 that is bound to β-arrestin. β-Arrestin recruitment prevents further G protein coupling and β-arrestin ubiquitination allows it to form signaling and endocytic complexes, facilitating both receptor endocytosis and MAPK signaling. Step 4, β-arrestin conformational changes that occur upon receptor binding allow its interaction with Nedd4, which probably displaces Mdm2 from β-arrestin (5–15 min after agonist treatment). Step 5, by interacting simultaneously with β2AR, clathrin, and AP-2, β-arrestin2 facilitates β2AR endocytosis. Step 6, β-arrestin2 is deubiquitinated by an as-yet unidentified process, leading to its disengagement from the receptor complex (10–15 min after agonist treatment). Nedd4 mediates ubiquitination of the endosomally located β2AR. Step 7, ubiquitinated β2ARs move on into early endosomes (at >15 min after activation). Step 8, β2AR ubiquitination persists until about 6 h after agonist stimulation, when β2ARs move into late endosomal/lysosomal compartments. Step 9, level of ubiquitinated β2ARs decreases, as ubiquitinated receptors are degraded in lysosomes (6–24 h or more after agonist stimulation). Step 10, from the early endosomes, receptors may take up an alternate path and enter recycling endosomes (<15–30 min after activation), in which β2ARs become dephosphorylated and perhaps deubiquitinated, and return to the plasma membrane as “naïve receptors” (Step 11).